Janus Henderson Global Life Sciences Fund
Not enough financial coverage to compute a composite score for JAGLX. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companywww.janushenderson.com/en-us/advisor/product/global-life-sciences-fund
The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio manager believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.
- IPO
- 1998
- HQ
- Denver, CO, US
Price Chart
Valuation
- Market Cap
- $5.32B
- Div Yield
- 4.59%
Performance & Tape
- 52W High
- $84.43
- 52W Low
- $63.15
- 50D MA
- $78.27
- 200D MA
- $76.99
- Beta
- 0.72
- Avg Volume
- 0
Get TickerSpark's AI analysis on JAGLX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our JAGLX Coverage
We haven't published any research on JAGLX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate JAGLX Report →